Advertisement
Research Article Free access | 10.1172/JCI106274
Division of Hematology of the Department of Medicine of the Children's Hospital Medical Center, Boston, Massachusetts 02115
Department of Pediatrics of the Harvard Medical School, Boston, Massachusetts 02115
Find articles by Kan, Y. in: PubMed | Google Scholar
Division of Hematology of the Department of Medicine of the Children's Hospital Medical Center, Boston, Massachusetts 02115
Department of Pediatrics of the Harvard Medical School, Boston, Massachusetts 02115
Find articles by Nathan, D. in: PubMed | Google Scholar
Published April 1, 1970 - More info
Homozygous thalassemia is due to inherited unbalanced synthesis of the α- or β-chains of hemoglobin. Clinical severity may be in part related to the extent of α:β imbalance. Two families are presented that illustrate this concept. Thalassemia in these individuals was evaluated by clinical and genetic criteria. The relative rates of α- and β-chain synthesis in their reticulocytes were estimated by the extent of incorporation of 1-leucine—U-14C into the chains. Unusual combinations of clinical and hematological data and biosynthetic ratios were obtained in certain individuals which indicated the presence of combinations of α- and β-thalassemia genes. The propositus of the first family had mild Cooley's anemia and was believed to have one α- as well as two β-thalassemia genes. Presumably the α-thalassemia gene interfered with α-chain production which lead to less accumulation of α-chains and a reduced rate of intramedullary and peripheral hemolysis. In the second family two individuals were believed to have an α-thalassemia, a “silent carrier,” and a β-thalassemia gene. Despite the fact that they appeared to have the genotype of hemoglobin H disease, their cells contained no hemoglobin H and had a normal lifespan presumably because excess β-chain production was inhibited by the β-thalessemia gene. These family studies suggest that the α:β imbalance observed in thalassemia may be favorably influenced by combinations of α- and β-thalassemia genes.